Capital Flow Monitor · Sponsors · CIK 1670747
BirchBioMed Inc.
130 KINGSCROSS DRIVE, KING CITY, A6, L7B 1E6 · 905-833-3414
Biotechnology · Corporation· inc. BRITISH COLUMBIA, CANADA true
Fit score
—
Offering
$5.0M
Sold
$2.5M
% sold
49.6%
Investors
18
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-01 | D/A ·current | 506(b) | $5.0M | $2.5M | 49.6% | 18 | EDGAR ↗ |
| 2025-07-11 | D | 506(b) | $3.0M | $175K | 5.8% | 5 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Mark Miller — Executive Officer / Director / Promoter, King City, A6
4 other raises
- Voxcell BioInnovation Inc. $2.2M of $2.2M · 100.0%
- RarePh8,Inc. $500K of $1.1M · 47.3%
- Pishon Capital Fund LP $4.4M of —
- Modelwise Technologies Inc. $975K of $1.0M · 97.5%
- John Verbeck — Executive Officer, King City, A6
- Susan Elliott — Executive Officer / Director / Promoter, King City, A6
- Carlos Camozzi — Executive Officer, King City, A6
- Teresa Bair — Director, King City, A6
- Charles Ellis — Director, King City, A6
- Joseph Sardano — Director, King City, A6
- Herve Girsault — Executive Officer, King City, A6
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.